Evidence map›Paper›PMID 28418697›Full record

ArticleAmerican journal of respiratory and critical care medicine2017

A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis.

Carmen Mikacenic, Brenda L Price, Susanna Harju-Baker, D Shane O'Mahony, Cassianne Robinson-Cohen, Frank Radella, William O Hahn, Ronit Katz, David C Christiani, Jonathan Himmelfarb and 2 more

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Observational
  19. Observational
  20. A 2-Biomarker Model Augments Clinical Prediction of Mortality in Melioidosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Carmen Mikacenic1 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Brenda L Price2 Department of Biostatistics.
Susanna Harju-Baker1 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
D Shane O'Mahony3 Department of Pulmonary and Critical Care Medicine, Swedish Medical Center, Seattle, Washington.
Cassianne Robinson-Cohen4 Kidney Research Institute, and.
Frank Radella1 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
William O Hahn5 Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.
Ronit Katz4 Kidney Research Institute, and.
David C Christiani6 Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and.
Jonathan Himmelfarb4 Kidney Research Institute, and.
W Conrad Liles5 Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.
Mark M Wurfel1 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Pulmonary and Critical Care Associates · USKidney Research UK · GBUniversity of Washington · USCancer Research And Biostatistics · USHarvard University · USSwedish Medical Center · US

Funding

SCCOR in Translational Research in Acute Lung InjuryP50HL073996 · NHLBI · UNIVERSITY OF WASHINGTON · PI RUBENS, CRAIG E. · 2003 to 2007
$15.7M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
MOLECULAR EPIDEMIOLOGY OF ARDSR01HL060710 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2000 to 2015
$8.4M
Influence of TLR1 Polymorphisms on T-Regulatory Cells in ARDSK23HL120896 · NHLBI · UNIVERSITY OF WASHINGTON · PI MIKACENIC, CARMEN R · 2014 to 2018
$881k
NHLBI NIH HHS K23 HL120896NHLBI NIH HHS P50 HL073996NHLBI NIH HHS R01 HL060710NIAID NIH HHS T32 AI007044
6 · The paper itself

Abstract

rationaleImproving the prospective identification of patients with systemic inflammatory response syndrome (SIRS) and sepsis at low risk for organ dysfunction and death is a major clinical challenge.

objectivesTo develop and validate a multibiomarker-based prediction model for 28-day mortality in critically ill patients with SIRS and sepsis.

methodsA derivation cohort (n = 888) and internal test cohort (n = 278) were taken from a prospective study of critically ill intensive care unit (ICU) patients meeting two of four SIRS criteria at an academic medical center for whom plasma was obtained within 24 hours. The validation cohort (n = 759) was taken from a prospective cohort enrolled at another academic medical center ICU for whom plasma was obtained within 48 hours. We measured concentrations of angiopoietin-1, angiopoietin-2, IL-6, IL-8, soluble tumor necrosis factor receptor-1, soluble vascular cell adhesion molecule-1, granulocyte colony-stimulating factor, and soluble Fas. MEASUREMENTS AND MAIN

resultsWe identified a two-biomarker model in the derivation cohort that predicted mortality (area under the receiver operator characteristic curve [AUC], 0.79; 95% confidence interval [CI], 0.74-0.83). It performed well in the internal test cohort (AUC, 0.75; 95% CI, 0.65-0.85) and the external validation cohort (AUC, 0.77; 95% CI, 0.72-0.83). We determined a model score threshold demonstrating high negative predictive value (0.95) for death. In addition to a low risk of death, patients below this threshold had shorter ICU length of stay, lower incidence of acute kidney injury, acute respiratory distress syndrome, and need for vasopressors.

conclusionsWe have developed a simple, robust biomarker-based model that identifies patients with SIRS/sepsis at low risk for death and organ dysfunction.

Indexed as

AdultAgedAged, 80 and overAngiopoietinsBiomarkersCohort StudiesCritical IllnessFemaleGranulocyte Colony-Stimulating FactorHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesSepsisSystemic Inflammatory Response SyndromeAngiopoietinsBiomarkersGranulocyte Colony-Stimulating FactorTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1biomarkersIL-8sepsissystemic inflammatory response syndrometumor necrosis factor receptor

Identifiers

PMID28418697
PMCPMC5649981
OpenAlexW2607338654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.